Social Pulse: Grifols SA (GRLS.MC)
GRLS.MC on Madrid SE C.A.T.S.
27.35EUR
5:35am EDT
27.35EUR
5:35am EDT
Price Change (% chg)
€-0.11 (-0.40%)
€-0.11 (-0.40%)
Prev Close
€27.46
€27.46
Open
€27.25
€27.25
Day's High
€27.37
€27.37
Day's Low
€26.86
€26.86
Volume
82,460
82,460
Avg. Vol
609,931
609,931
52-wk High
€32.04
€32.04
52-wk Low
€18.78
€18.78
Press Releases
- Grifols Announces First Patient Enrolled and Dosed in Phase II Trial of Alpha-1 HC Aerosol to Treat Cystic Fibrosis
- Grifols announces robust inventory of HyperRAB® S/D rabies immune globulin for treatment of rabies exposure
- Grifols Awards Winners of the 9th Annual eALTA Research Fellowship at 2012 ERS Meeting
- Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
- Grifols Publishes Positive Phase I Safety Results for Plasmin, a Novel, Direct-Acting Thrombolytic, in the Journal of Thrombosis and Haemostasis
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
